Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 3Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 86Recurrence 14Neoplasms, Plasma Cell 14Lymphoma, Non-Hodgkin 9Lymphoma 7Leukemia, Plasma Cell 6Immunoglobulin Light-chain Amyloidosis 5Smoldering Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Primary Myelofibrosis 2POEMS Syndrome 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Hematologic Neoplasms 2Fasting 2Burkitt Lymphoma 2Alzheimer Disease 2Waldenstrom Macroglobulinemia 1Vomiting 1Vitamin D Deficiency 1Thrombocythemia, Essential 1

Interventions

Ondansetron 1Dexamethasone 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Nausea × Plasma cell × Clear all
NCT00314743 2013-05-24

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
48 enrolled
Plasma cell

Multiple Myeloma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡